1. Functional inhibition of PAR2 alleviates allergen‐induced airway hyperresponsiveness and inflammation. Issue 12 (December 2015) Authors: Asaduzzaman, M.; Nadeem, A.; Arizmendi, N.; Davidson, C.; Nichols, H. L.; Abel, M.; Ionescu, L. I.; Puttagunta, L.; Thebaud, B.; Gordon, J.; DeFea, K.; Hollenberg, M. D.; Vliagoftis, H. Journal: Clinical & experimental allergy Issue: Volume 45:Issue 12(2015:Dec.) Page Start: 1844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Proteinase‐activated receptor‐2 blockade inhibits changes seen in a chronic murine asthma model. Issue 2 (11th October 2017) Authors: Asaduzzaman, M.; Davidson, C.; Nahirney, D.; Fiteih, Y.; Puttagunta, L.; Vliagoftis, H. Journal: Allergy Issue: Volume 73:Issue 2(2018) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗